World TB Day 2014: Finding the missing 3 million

The Lancet

Volumn 383, Issue 9922, 2014, Pages 1016-1018

  Herbert, Nick ^a   George, Andrew ^a   Masham Of Ilton, Baroness ^a   Sharma, Virendra ^a   Oliver, Matt ^b   Oxley, Aaron ^b   Raviglione, Mario ^c   Zumla, Alimuddin I ^d  

^a All Party Parliamentary Group on Global Tuberculosis   (United Kingdom)

^b Resultancy   (United Kingdom)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG RESISTANT TUBERCULOSIS; EPIDEMIC; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALARIA; MULTIDRUG RESISTANCE; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH; RELAPSE; TREATMENT FAILURE; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GOVERNMENT; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; PREVALENCE; PUBLIC HEALTH PROBLEM;

COMMUNICABLE DISEASE CONTROL; HUMANS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; WORLD HEALTH ORGANIZATION;

EID: 84921319291     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60422-0     Document Type: Note

References (13)

1. WHO. TB-a global emergency. WHO press release. WHO/31 Geneva: World Health Organisation, 1993
2. WHO. Global tuberculosis report 2013. Geneva: World Health Organization, 2013. http://www.who.int/tb/publications/globalreport/en/ (accessed Jan 29, 2014)
3. Raviglione M. Post-2015 TB strategy and targets: draft document and results of consultations. Presentation from 3rd Stop TB Partnership Coordinating Board Meeting; July 11-12, 2013; Ottawa, Canada.http:// www.stoptb.org/assets/ documents/about/cb/meetings/23/1.13-0%20Presentations/ Session%2006Post%202015%20StrategyRaviglione.pdf (accessed Feb 28, 2014)
4. Zumla A, George A, Sharma V, Herbert N, Baroness Masham of Ilton WHO's 2013 global report on tuberculosis: successes, threats, and opportunities. Lancet 2013; 382: 1765-67
5. Pietersen E, Ignatius E, Streicher EM, et al. Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study Lancet 2014; published online Jan 16. http:dx.doi.org/10.1016/S0140- 6736(13)62675-6
6. Bates M, O'Grady J, Mwaba P, et al. Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients. PLoS One 2012; 7: e40774
7. O'Grady J, Bates M, Chilukutu L, et al. Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic. Clin Infect Dis 2012; 55: 1171-78
8. Bates M, Ahmed Y, Chilukutu L, et al. Use of the Xpert® MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia. Trop Med Int Health 2013; 18: 1134-40
9. Corbett EL, Bandason T, Duong T, et al. Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial. Lancet 2010; 376: 1244-53
10. Ayles H, Muyoyeta M, Du Toit E, et al. Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial. Lancet 2013; 382: 1183-94
11. Zumla AI, Gillespie SH, Hoelscher M, et al. New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects Lancet Infect Dis 2014; published online March 24. http://dx.doi.org/10.1016/ S1473-3099(13)70328-1
12. Kaufmann SHE, Lange C, Rao M, et al. Progress in tuberculosis vaccine development and host-directed therapies-a state of the art review Lancet Respir Med 2014; published online March 24. http://dx.doi org/10.1016/S2213-2600(14) 70033-5
13. McNerney R, Maeurer M, Abubakar I, et al. Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis 2012; 205 (suppl 2): S147-58